Meeder Advisory Services Inc. Invests $2.62 Million in Danaher Corporation $DHR

Meeder Advisory Services Inc. bought a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 13,756 shares of the conglomerate’s stock, valued at approximately $2,620,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Meeder Asset Management Inc. purchased a new position in Danaher in the second quarter valued at approximately $44,000. Citizens Financial Group Inc. RI purchased a new stake in Danaher during the second quarter worth approximately $4,197,000. Texas Capital Bank Wealth Management Services Inc purchased a new stake in Danaher during the second quarter worth approximately $7,965,000. Cornerstone Advisors LLC acquired a new stake in shares of Danaher in the second quarter worth $6,196,000. Finally, Aegis Wealth Management LLC purchased a new position in shares of Danaher in the 2nd quarter valued at $200,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Guggenheim lowered their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. UBS Group dropped their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. Finally, Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Check Out Our Latest Stock Analysis on DHR

Danaher Stock Performance

Shares of DHR opened at $199.62 on Wednesday. The firm’s 50 day moving average is $193.74 and its 200-day moving average is $192.50. The stock has a market capitalization of $140.33 billion, a P/E ratio of 35.46, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 earnings per share. Equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.